Abstract
Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.
Original language | English |
---|---|
Patent number | 8852588 |
Publication status | Published - 1800 |